Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania

Mohammad A. Al-Wabel, Willy K. Tonui, Liwang Cui, Samuel K. Martin, Richard G. Titus

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Leishmania major culture-derived, soluble, exogenous antigens have been shown to be a source of vaccine targets for the parasite. We have previously reported that L. major culture-derived, soluble, exogenous antigens can immunize BALB/c mice against challenge with L. major. However, the molecule(s) involved in this protection was not known. We describe the potential of one component of soluble exogenous antigens (recombinant nucleoside hydrolase) to vaccinate mice against challenge with L. major. We found that recombinant nucleoside hydrolase vaccinated BALB/c mice against a subsequent challenge with L. major. Protection was manifested by a significant decrease in lesion size (as much as a 30-fold reduction) and parasite burden (as much as a 71-fold reduction). Protection was achieved whether recombinant nucleoside hydrolase was administered to mice in the presence or absence of adjuvant (interleukin-12) Finally, protection was accompanied by an increase in interferon-γ production but a decrease in interleukin-10 production by vaccinated animals in response to challenge with L. major.

Original languageEnglish (US)
Pages (from-to)1060-1065
Number of pages6
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume77
Issue number6
StatePublished - Dec 1 2007

Fingerprint

N-Glycosyl Hydrolases
Leishmania major
Leishmania
Antigens
Parasites
Interleukin-12
Interleukin-10
Interferons
Vaccines

All Science Journal Classification (ASJC) codes

  • Parasitology
  • Virology
  • Infectious Diseases

Cite this

Al-Wabel, Mohammad A. ; Tonui, Willy K. ; Cui, Liwang ; Martin, Samuel K. ; Titus, Richard G. / Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania. In: American Journal of Tropical Medicine and Hygiene. 2007 ; Vol. 77, No. 6. pp. 1060-1065.
@article{733f6ab7b29b4658b76a2b01f34affd0,
title = "Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania",
abstract = "Leishmania major culture-derived, soluble, exogenous antigens have been shown to be a source of vaccine targets for the parasite. We have previously reported that L. major culture-derived, soluble, exogenous antigens can immunize BALB/c mice against challenge with L. major. However, the molecule(s) involved in this protection was not known. We describe the potential of one component of soluble exogenous antigens (recombinant nucleoside hydrolase) to vaccinate mice against challenge with L. major. We found that recombinant nucleoside hydrolase vaccinated BALB/c mice against a subsequent challenge with L. major. Protection was manifested by a significant decrease in lesion size (as much as a 30-fold reduction) and parasite burden (as much as a 71-fold reduction). Protection was achieved whether recombinant nucleoside hydrolase was administered to mice in the presence or absence of adjuvant (interleukin-12) Finally, protection was accompanied by an increase in interferon-γ production but a decrease in interleukin-10 production by vaccinated animals in response to challenge with L. major.",
author = "Al-Wabel, {Mohammad A.} and Tonui, {Willy K.} and Liwang Cui and Martin, {Samuel K.} and Titus, {Richard G.}",
year = "2007",
month = "12",
day = "1",
language = "English (US)",
volume = "77",
pages = "1060--1065",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "6",

}

Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania. / Al-Wabel, Mohammad A.; Tonui, Willy K.; Cui, Liwang; Martin, Samuel K.; Titus, Richard G.

In: American Journal of Tropical Medicine and Hygiene, Vol. 77, No. 6, 01.12.2007, p. 1060-1065.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania

AU - Al-Wabel, Mohammad A.

AU - Tonui, Willy K.

AU - Cui, Liwang

AU - Martin, Samuel K.

AU - Titus, Richard G.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Leishmania major culture-derived, soluble, exogenous antigens have been shown to be a source of vaccine targets for the parasite. We have previously reported that L. major culture-derived, soluble, exogenous antigens can immunize BALB/c mice against challenge with L. major. However, the molecule(s) involved in this protection was not known. We describe the potential of one component of soluble exogenous antigens (recombinant nucleoside hydrolase) to vaccinate mice against challenge with L. major. We found that recombinant nucleoside hydrolase vaccinated BALB/c mice against a subsequent challenge with L. major. Protection was manifested by a significant decrease in lesion size (as much as a 30-fold reduction) and parasite burden (as much as a 71-fold reduction). Protection was achieved whether recombinant nucleoside hydrolase was administered to mice in the presence or absence of adjuvant (interleukin-12) Finally, protection was accompanied by an increase in interferon-γ production but a decrease in interleukin-10 production by vaccinated animals in response to challenge with L. major.

AB - Leishmania major culture-derived, soluble, exogenous antigens have been shown to be a source of vaccine targets for the parasite. We have previously reported that L. major culture-derived, soluble, exogenous antigens can immunize BALB/c mice against challenge with L. major. However, the molecule(s) involved in this protection was not known. We describe the potential of one component of soluble exogenous antigens (recombinant nucleoside hydrolase) to vaccinate mice against challenge with L. major. We found that recombinant nucleoside hydrolase vaccinated BALB/c mice against a subsequent challenge with L. major. Protection was manifested by a significant decrease in lesion size (as much as a 30-fold reduction) and parasite burden (as much as a 71-fold reduction). Protection was achieved whether recombinant nucleoside hydrolase was administered to mice in the presence or absence of adjuvant (interleukin-12) Finally, protection was accompanied by an increase in interferon-γ production but a decrease in interleukin-10 production by vaccinated animals in response to challenge with L. major.

UR - http://www.scopus.com/inward/record.url?scp=39049127054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049127054&partnerID=8YFLogxK

M3 - Article

C2 - 18165522

AN - SCOPUS:39049127054

VL - 77

SP - 1060

EP - 1065

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 6

ER -